GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-07-06 1391f30fa9m

请问限制多少字呢？tmmutiger 2017-04-29 发表::
接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表:
不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦

tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦

1029 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-05-25 1771ea5e29m

您好，lovetcm 2017-04-28 发表::
要写临床价值大的meta，如dose response meta

lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta

920 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-04-29 tmmutiger

审稿速度:1.0 | 投稿命中率:5.0
经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦

978 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-04-28 lovetcm

要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表::
meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表:
meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点

外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点

1000 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-04-12 sy3923582

是的L2X496 2016-11-15 发表::
no unsolicited reviews will be considered 意思是只接受约稿吗？急！

L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！

1062 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-04-11 sy3923582

不一定zpfsjtu 2016-02-01 发表::
研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。

zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。

1186 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2017-01-05 Kobe Byrant

meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表::
接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！

slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！

995 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2016-11-15 L2X496

no unsolicited reviews will be considered 意思是只接受约稿吗？急！

425 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2016-11-13 纵然情深,奈何爱浅

要收投稿费?gzhjjx 2015-10-09 发表::
同样秒拒，握爪！

gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！

414 0

[GetPortalCommentsPageByObjectIdResponse(id=538657, encodeId=838053865e80, content=请问限制多少字呢？tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦tmmutiger 2017-04-29 13:01:00 发表: 不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=tmmutiger 2017-04-29 发表:: 接收率：约5% 审稿时间：约1个月不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1029, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e88d2085240, createdName=1391f30fa9m, createdTime=Thu Jul 06 00:00:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537127, encodeId=890053e12760, content=您好，lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , beContent=lovetcm 2017-04-28 发表:: 要写临床价值大的meta，如dose response meta , objectType=tool_impact_factor, channel=null, level=null, likeNumber=920, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbfc2044311, createdName=1771ea5e29m, createdTime=Thu May 25 21:39:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536163, encodeId=94dc53616378, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：不说了,收了75美元就秒拒,唉,字数超了,投其他杂志还要修改字数,很是麻烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqsLwuJ7ViaKemmWshOwU2q27mtWAhSJRXn5QZbNb9prSobY0xeJ3hMdw1wbqcgRqZ0ibFoep6WTH6g/132, createdBy=179888220, createdName=tmmutiger, createdTime=Sat Apr 29 13:01:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536140, encodeId=b6625361403d, content=要写临床价值大的meta，如dose response meta 外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点外科圣手 2017-01-05 00:53:00 发表: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, beContent=外科圣手 2017-01-05 发表:: meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1000, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Apr 28 00:00:00 CST 2017, time=2017-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535467, encodeId=31cb53546e19, content=是的L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=L2X496 2016-11-15 发表:: no unsolicited reviews will be considered 意思是只接受约稿吗？急！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1062, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Wed Apr 12 13:33:00 CST 2017, time=2017-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535415, encodeId=c228535415f1, content=不一定zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, beContent=zpfsjtu 2016-02-01 发表:: 研究方向：肝癌;泛素化; 这个杂志都是什么状态呀。昨天投稿，今天就under review。应该不会这么快吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epr1MZHfgreGEFrpiapjCGIQGZhkpjicialc8h7VoU0AjNiaSgpaZjNuIqq1KVbmI19JwrN2sdwTdWVSw/132, createdBy=f6692009961, createdName=sy3923582, createdTime=Tue Apr 11 11:16:00 CST 2017, time=2017-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531453, encodeId=ee97531453e9, content=meta有什么要求吗？是临床治疗类还是诊断类？我也想尝试投一篇求指点slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, beContent=slientwo 2016-09-25 发表:: 接收率：约25% 审稿时间：约1个月 Meta分析，在投，under review，5天。会不会不送外审就被拒！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=995, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/cd7766c7f7b6194d91ad94686c8a4352.jpg, createdBy=daad1978009, createdName=Kobe Byrant, createdTime=Thu Jan 05 00:53:00 CST 2017, time=2017-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529408, encodeId=67665294080b, content=no unsolicited reviews will be considered 意思是只接受约稿吗？急！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5051957123, createdName=L2X496, createdTime=Tue Nov 15 20:51:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529317, encodeId=c58d52931e43, content=要收投稿费?gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, beContent=gzhjjx 2015-10-09 发表:: 同样秒拒，握爪！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b66a1603816, createdName=纵然情深,奈何爱浅, createdTime=Sun Nov 13 14:55:00 CST 2016, time=2016-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527763, encodeId=a2b252e763ae, content=投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, beContent=哇咔咔 2016-09-29 发表:: 可以尝试修改后再投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Thu Sep 29 23:05:00 CST 2016, time=2016-09-29, status=1, ipAttribution=)]

2016-09-29 slientwo

投了APT被秒拒，心如死灰。字数又多，真的不知道该投什么杂志了哇咔咔 2016-09-29 发表::
可以尝试修改后再投

哇咔咔 2016-09-29 发表:: 可以尝试修改后再投

388 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务